American Portfolios Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

American Portfolios Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$689	Hold	13	–	–	﹤0.01%	3338
2022 Q2	$714	Hold	13	–	–	﹤0.01%	3343
2022 Q1	$900	Hold	13	–	–	﹤0.01%	3393
2021 Q4	$1.24K	Hold	13	–	–	﹤0.01%	3290
2021 Q3	$1.11K	Hold	13	–	–	﹤0.01%	3278
2021 Q2	$1.05K	Hold	13	–	–	﹤0.01%	3256
2021 Q1	$1.22K	Hold	13	–	–	﹤0.01%	3098
2020 Q4	$796	Sell	13 -104	-89%	-$5.93K	﹤0.01%	2867
2020 Q3	$6.96K	Hold	117	–	–	﹤0.01%	2139
2020 Q2	$8.16K	Hold	117	–	–	﹤0.01%	2010
2020 Q1	$5.31K	Buy	117 +18	+18%	+$1.02K	﹤0.01%	2062
2019 Q4	$6.47K	Hold	99	–	–	﹤0.01%	2170
2019 Q3	$6.17K	Buy	99 +19	+24%	+$1.19K	﹤0.01%	2114
2019 Q2	$5.71K	Sell	80 -26	-25%	-$1.92K	﹤0.01%	2133
2019 Q1	$8.3K	Sell	106 -30	-22%	-$2.27K	﹤0.01%	1902
2018 Q4	$11.5K	Buy	136 +67	+97%	+$7.14K	﹤0.01%	1570
2018 Q3	$11.8K	Sell	69 -24	-26%	-$3.62K	﹤0.01%	1696
2018 Q2	$12K	Hold	93	–	–	﹤0.01%	1654
2018 Q1	$9.58K	Hold	93	–	–	﹤0.01%	1648
2017 Q4	$7.94K	Buy	+93	New	+$8.06K	﹤0.01%	1643

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

American Portfolios Advisors's LGND Position: Q3 2022 in Review

American Portfolios Advisors held its Ligand Pharmaceuticals (LGND) position steady in Q3 2022 at 13 shares worth $689. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

American Portfolios Advisors first reported a position in LGND in Q4 2017 and has held it in 20 quarters since. The position peaked at $12K in Q2 2018. 205 funds tracked by Wall St. Rank hold LGND as of Q3 2022.

American Portfolios Advisors held 13 shares of Ligand Pharmaceuticals worth $689 as of Q3 2022.
American Portfolios Advisors left its Ligand Pharmaceuticals share count unchanged in Q3 2022.
Ligand Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3338 holding.
American Portfolios Advisors first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Ligand Pharmaceuticals position peaked at $12K in Q2 2018.
205 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.